Addressing the opioid crisis should be the top priority for the Food and Drug Administration, Scott Gottlieb, President Donald Trump's nominee to lead the agency, told a Senate panel.
Gottlieb told the Senate Health, Education, Labor and Pensions Committee during a Wednesday confirmation hearing that addressing the opioid crisis would “require dramatic action” from the FDA.
